Knocking down 10-Formyltetrahydrofolate dehydrogenase increased oxidative stress and impeded zebrafish embryogenesis by obstructing morphogenetic movement.

Biochim Biophys Acta

Institute of Basic Medical Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. Electronic address:

Published: July 2014

Background: Folate is an essential nutrient for cell survival and embryogenesis. 10-Formyltetrahydrofolate dehydrogenase (FDH) is the most abundant folate enzyme in folate-mediated one-carbon metabolism. 10-Formyltetrahydrofolate dehydrogenase converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2, the only pathway responsible for formate oxidation in methanol intoxication. 10-Formyltetrahydrofolate dehydrogenase has been considered a potential chemotherapeutic target because it was down-regulated in cancer cells. However, the normal physiological significance of 10-Formyltetrahydrofolate dehydrogenase is not completely understood, hampering the development of therapeutic drug/regimen targeting 10-Formyltetrahydrofolate dehydrogenase.

Methods: 10-Formyltetrahydrofolate dehydrogenase expression in zebrafish embryos was knocked-down using morpholino oligonucleotides. The morphological and biochemical characteristics of fdh morphants were examined using specific dye staining and whole-mount in-situ hybridization. Embryonic folate contents were determined by HPLC.

Results: The expression of 10-formyltetrahydrofolate dehydrogenase was consistent in whole embryos during early embryogenesis and became tissue-specific in later stages. Knocking-down fdh impeded morphogenetic movement and caused incorrect cardiac positioning, defective hematopoiesis, notochordmalformation and ultimate death of morphants. Obstructed F-actin polymerization and delayed epiboly were observed in fdh morphants. These abnormalities were reversed either by adding tetrahydrofolate or antioxidant or by co-injecting the mRNA encoding 10-formyltetrahydrofolate dehydrogenase N-terminal domain, supporting the anti-oxidative activity of 10-formyltetrahydrofolate dehydrogenase and the in vivo function of tetrahydrofolate conservation for 10-formyltetrahydrofolate dehydrogenase N-terminal domain.

Conclusions: 10-Formyltetrahydrofolate dehydrogenase functioned in conserving the unstable tetrahydrofolate and contributing to the intracellular anti-oxidative capacity of embryos, which was crucial in promoting proper cell migration during embryogenesis.

General Significance: These newly reported tetrahydrofolate conserving and anti-oxidative activities of 10-formyltetrahydrofolate dehydrogenase shall be important for unraveling 10-formyltetrahydrofolate dehydrogenase biological significance and the drug development targeting 10-formyltetrahydrofolate dehydrogenase.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2014.04.009DOI Listing

Publication Analysis

Top Keywords

10-formyltetrahydrofolate dehydrogenase
56
10-formyltetrahydrofolate
15
dehydrogenase
14
morphogenetic movement
8
targeting 10-formyltetrahydrofolate
8
fdh morphants
8
dehydrogenase n-terminal
8
tetrahydrofolate
5
knocking 10-formyltetrahydrofolate
4
dehydrogenase increased
4

Similar Publications

Accumulation of Cerebrospinal Fluid, Ventricular Enlargement, and Cerebral Folate Metabolic Errors Unify a Diverse Group of Neuropsychiatric Conditions Affecting Adult Neocortical Functions.

Int J Mol Sci

September 2024

Division of Neuroscience, Faculty of Biology, Medicine & Health, School of Biological Science, The University of Manchester, 3.540 Stopford Building, Oxford Road, Manchester M13 9PT, UK.

Article Synopsis
  • Cerebrospinal fluid (CSF) is vital for brain health, providing nutrients, signaling, and removing toxins while supporting brain development and function.
  • The study examined folate transport in CSF, focusing on key proteins that move folate from blood into CSF and then into brain cells, linking folate status to neurological conditions with ventricular enlargement.
  • Findings indicate that various neurological conditions show distinct folate imbalances, suggesting that addressing these imbalances could help alleviate symptoms and deficits related to these conditions.
View Article and Find Full Text PDF

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.

Cell Metab

August 2024

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, P.R. China; Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, P.R. China; China National Clinical Research Center for Neurological Diseases, Beijing 100070, P.R. China; Brain Tumor Center, Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100070, P.R. China; Beijing Engineering Research Center of Targeted Drugs and Cell Therapy for CNS Tumors, Beijing 102600, P.R. China; Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA), Beijing 100070, P.R. China. Electronic address:

Article Synopsis
  • Patients with high ALDH1A3-expressing glioblastoma show limited response to standard chemoradiotherapy, making it vital to explore resistance mechanisms for better treatment options.
  • The interaction between ALDH1A3 and PKM2 promotes PKM2's tetramerization and lactate production, which aids in DNA repair by enhancing the function of XRCC1 through its lactylation.
  • A small molecule, D34-919, disrupts the ALDH1A3-PKM2 interaction, improving the effectiveness of chemoradiotherapy by increasing apoptosis in GBM cells, highlighting a new potential therapeutic target.
View Article and Find Full Text PDF

FOXO1 induced fatty acid oxidation in hepatic cells by targeting ALDH1L2.

J Gastroenterol Hepatol

October 2024

Department of Gastroenterology and Hepatology, Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China.

Background And Aim: Lipid metabolism disorder is the primary feature of numerous refractory chronic diseases. Fatty acid oxidation, an essential aerobic biological process, is closely related to the progression of NAFLD. The forkhead transcription factor FOXO1 has been reported to play an important role in lipid metabolism.

View Article and Find Full Text PDF

Structural identification and comprehension of human ALDH1L1-Gossypol complex.

Biochem Biophys Res Commun

September 2024

Department of Molecular Biology, College of Natural Sciences, Pusan National University, 2, Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan, 46241, Republic of Korea. Electronic address:

The folate metabolism enzyme ALDH1L1 catalyzed 10-formyltetrahydrofolate to tetrahydrofolate and CO. Non-small cell lung cancer cells (NSCLC) strongly express ALDH1L1. Gossypol binds to an allosteric site and disrupts the folate metabolism by preventing NADP binding.

View Article and Find Full Text PDF

ALDH1L2, a mitochondrial enzyme in folate metabolism, converts 10-formyl-THF (10-formyltetrahydrofolate) to THF (tetrahydrofolate) and CO. At the cellular level, deficiency of this NADP-dependent reaction results in marked reduction in NADPH/NADP ratio and reduced mitochondrial ATP. Thus far, a single patient with biallelic ALDH1L2 variants and the phenotype of a neurodevelopmental disorder has been reported.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!